Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,082 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program).
Nagashima M, Koyanagi R, Kasanuki H, Hagiwara N, Yamaguchi J, Atsuchi N, Honda T, Haze K, Sumiyoshi T, Urashima M, Ogawa H; Heart Institute of Japan, Department of Cardiology (HIJC) Investigators. Nagashima M, et al. Among authors: yamaguchi j. Am J Cardiol. 2007 Jun 1;99(11):1523-8. doi: 10.1016/j.amjcard.2007.01.024. Epub 2007 Apr 16. Am J Cardiol. 2007. PMID: 17531574
Serum creatinine on admission predicts long-term mortality in acute myocardial infarction patients undergoing successful primary angioplasty: data from the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry.
Yamaguchi J, Kasanuki H, Ishii Y, Yagi M, Nagashima M, Fujii S, Koyanagi R, Ogawa H, Hagiwara N, Haze K, Sumiyoshi T, Honda T; HIJC Investigators. Yamaguchi J, et al. Circ J. 2007 Sep;71(9):1354-9. doi: 10.1253/circj.71.1354. Circ J. 2007. PMID: 17721010 Free article.
Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE).
Kasanuki H, Hagiwara N, Hosoda S, Sumiyoshi T, Honda T, Haze K, Nagashima M, Yamaguchi J, Origasa H, Urashima M, Ogawa H; HIJ-CREATE Investigators. Kasanuki H, et al. Among authors: yamaguchi j. Eur Heart J. 2009 May;30(10):1203-12. doi: 10.1093/eurheartj/ehp101. Epub 2009 Apr 4. Eur Heart J. 2009. PMID: 19346521 Clinical Trial.
Effect of amlodipine + candesartan on cardiovascular events in hypertensive patients with coronary artery disease (from The Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] Study).
Yamaguchi J, Hagiwara N, Ogawa H, Koyanagi R, Kasanuki H, Takagi A, Mori F, Nagashima M, Yagi M; HIJ-CREATE Investigators. Yamaguchi J, et al. Am J Cardiol. 2010 Sep 15;106(6):819-24. doi: 10.1016/j.amjcard.2010.05.007. Epub 2010 Aug 2. Am J Cardiol. 2010. PMID: 20816122 Clinical Trial.
Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients.
Higashitani M, Mori F, Yamada N, Arashi H, Kojika A, Hoshi H, Minami Y, Yamaguchi J, Yamauchi T, Takagi A, Ogawa H, Hagiwara N. Higashitani M, et al. Among authors: yamaguchi j. Heart Vessels. 2011 Nov;26(6):582-9. doi: 10.1007/s00380-010-0110-4. Epub 2011 Jan 26. Heart Vessels. 2011. PMID: 21267582
Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes.
Hattori H, Minami Y, Mizuno M, Yumino D, Hoshi H, Arashi H, Nuki T, Sashida Y, Higashitani M, Serizawa N, Yamada N, Yamaguchi J, Mori F, Shiga T, Hagiwara N. Hattori H, et al. Among authors: yamaguchi j. Heart Vessels. 2013 May;28(3):345-51. doi: 10.1007/s00380-012-0252-7. Epub 2012 Apr 19. Heart Vessels. 2013. PMID: 22526380 Clinical Trial.
1,082 results